drugset / Trial / NCT03048123
HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) compared with transarterial chemoembolization (TACE) in patients with large and unresectable hepatocellular carcinoma staged BCLC A/B.
Timeline
- Start
- 2015-10-01
- Primary completion
- 2016-10-01
- Completion
- 2017-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EADM | Unknown | — | Other |
| Subject | Leucovorin | Small molecule | — | Other |
| Comparator | Lobaplatin | Small molecule | — | Other |
| Comparator | MMC | Unknown | — | Other |
| Subject | Oxaliplatin | Small molecule | — | Other |
| Subject | fluorouracil | Small molecule | — | Other |
| Comparator | lipiodol | Unknown | — | Other |